Mary Safrin Selected Research

staphylolysin

2/2012	Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis.
7/2009	Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Safrin Research Topics

Disease

3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2017 - 01/2016
3	Infections 02/2012 - 05/2004
2	Keratitis 02/2012 - 05/2004
1	Optic Nerve Injuries 12/2021
1	Ischemia 12/2021
1	Glaucoma 12/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Fibrosis (Cirrhosis) 01/2016
1	Inflammation (Inflammations) 02/2012
1	Edema (Dropsy) 02/2012
1	Abscess 02/2012
1	Endophthalmitis (Ophthalmia) 07/2009

Drug/Important Bio-Agent (IBA)

5	Peptide Hydrolases (Proteases)FDA Link 10/2017 - 05/2004
3	ProcollagenIBA 10/2017 - 01/2016
2	staphylolysinIBA 02/2012 - 07/2009
2	Methicillin (Metin)FDA Link 02/2012 - 05/2004
2	lipid-associated sialic acid (LASA)IBA 07/2009 - 05/2004
1	Retinaldehyde (Retinal)IBA 12/2021
1	Voltage-Gated Sodium ChannelsIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	CollagenIBA 01/2016
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Collagen Type I (Type I Collagen)IBA 01/2016
1	Collagen Type III (Type III Collagen)IBA 01/2016
1	Bovine Serum AlbuminIBA 02/2012
1	Therapeutic UsesIBA 02/2012
1	Vancomycin FDA LinkGeneric 05/2004
1	LysostaphinIBA 05/2004

Therapy/Procedure

2	Therapeutics 01/2016 - 07/2009
1	Injections 02/2012
1	Intravitreal Injections 07/2009